Epclusa
RxNorm concept 1799213, brand name (bn).
- RxCUI
- 1799213
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1799213 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- sofosbuvir 400 MG / velpatasvir 100 MG [Epclusa] (SBDC, ingredient of)
- sofosbuvir / velpatasvir Oral Tablet [Epclusa] (SBDF, ingredient of)
- Epclusa Oral Product (SBDG, ingredient of)
- Epclusa Pill (SBDG, ingredient of)
- sofosbuvir 400 MG / velpatasvir 100 MG Oral Tablet [Epclusa] (SBD, ingredient of)
- sofosbuvir 200 MG / velpatasvir 50 MG [Epclusa] (SBDC, ingredient of)
- sofosbuvir 200 MG / velpatasvir 50 MG Oral Tablet [Epclusa] (SBD, ingredient of)
- sofosbuvir 150 MG / velpatasvir 37.5 MG [Epclusa] (SBDC, ingredient of)
- Epclusa Pellet Product (SBDG, ingredient of)
- sofosbuvir / velpatasvir Oral Pellet [Epclusa] (SBDF, ingredient of)
- sofosbuvir 150 MG / velpatasvir 37.5 MG Oral Pellet [Epclusa] (SBD, ingredient of)
- sofosbuvir 200 MG / velpatasvir 50 MG Oral Pellet [Epclusa] (SBD, ingredient of)
- sofosbuvir (IN, tradename of)
- velpatasvir (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1799213 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1799213 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1799213. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.